F-STAR THERAPEUTICS INC - COM (FSTX)

CUSIP: 30315R107

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
7,169,414
Share change
-1,014,175
Total reported value
$44,879,979
Put/Call ratio
1506%
Price per share
$6.26
Number of holders
52
Value change
-$3,086,338
Number of buys
30
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 30315R107?
CUSIP 30315R107 identifies FSTX - F-STAR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of F-STAR THERAPEUTICS INC - COM (FSTX) as of Q2 2022

As of 30 Jun 2022, F-STAR THERAPEUTICS INC - COM (FSTX) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,169,414 shares. The largest 10 holders included VANGUARD GROUP INC, Rock Springs Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, Atlas Venture Life Science Advisors, LLC, DAFNA Capital Management LLC, Atlas Venture Advisors, Inc., Russell Investments Group, Ltd., BlackRock Inc., WELLS FARGO & COMPANY/MN, and CITADEL ADVISORS LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.